公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2010 | Pegylated interferon alfa-2a monotherapy for hemodialysis patients with acute hepatitis C | CHEN-HUA LIU ; Liang C.-C.; CHUN-JEN LIU ; JOU-WEI LIN ; Chen S.-I.; Hung P.-H.; Tsai H.-B.; Lai M.-Y.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Clinical Infectious Diseases | 30 | 26 | |
2009 | Pegylated interferon α-2a plus low-dose ribavirin for the retreatment of dialysis chronic hepatitis C patients who relapsed from prior interferon monotherapy | CHEN-HUA LIU ; Liang C.-C.; CHUN-JEN LIU ; Tsai H.-B.; Hung P.-H.; SHIH-JER HSU ; Chen S.-L.; JOU-WEI LIN ; Lai M.-Y.; Chen J.-H.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Gut | 26 | 23 | |
2008 | Pegylated interferon α-2a versus standard interferon α-2a for treatment-naïve dialysis patients with chronic hepatitis C: A randomised study | CHEN-HUA LIU ; Liang C.-C.; JOU-WEI LIN ; Chen S.-I.; Tsai H.-B.; Chang C.-S.; Hung P.-H.; JIA-HORNG KAO ; CHUN-JEN LIU ; Lai M.-Y.; Chen J.-H.; PEI-JER CHEN ; DING-SHINN CHEN | Gut | 67 | 61 | |
2008 | Pegylated interferon-α-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus genotype 1 infection: A multicenter, randomized controlled trial | CHEN-HUA LIU ; CHUN-JEN LIU ; Lin C.-L.; Liang C.-C.; SHIH-JER HSU ; Yang S.-S.; Hsu C.-S.; TAI-CHUNG TSENG ; Wang C.-C.; Lai M.-Y.; Chen J.-H.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Clinical Infectious Diseases | 183 | 170 | |
2005 | Percutaneous ethanol injection versus surgical resection for the treatment of small hepatocellular carcinoma: A prospective study | GUAN-TARN HUANG ; PO-HUANG LEE ; Tsang Y.-M.; Lai M.-Y.; PEI-MING YANG ; REY-HENG HU ; PEI-JER CHEN ; JIA-HORNG KAO ; JIN-CHUAN SHEU ; Lee, Cha-Ze ; DING-SHINN CHEN | Annals of Surgery | 177 | 163 | |
1997 | Positive and negative strand of hepatitis C virus RNA sequences in peripheral blood mononuclear cells in patients with chronic hepatitis C: No correlation with viral genotypes 1b, 2a, and 2b | JIA-HORNG KAO ; PEI-JER CHEN ; Lai M.-Y.; Wang T.-H.; DING-SHINN CHEN | Journal of Medical Virology | 45 | ||
2004 | Precore/Core Promoter Mutations and Genotypes of Hepatitis B Virus in Chronic Hepatitis B Patients with Fulminant or Subfulminant Hepatitis | CHUN-JEN LIU ; JIA-HORNG KAO ; Lai M.-Y.; PEI-JER CHEN ; DING-SHINN CHEN | Journal of Medical Virology | 39 | 37 | |
1995 | A predisposition toward edwardsiella tarda bacteremia in individuals with preexisting liver disease | MING-SHIANG WU ; Shyu R.-S.; Lai M.-Y.; GUAN-TARN HUANG ; DING-SHINN CHEN ; Wang T.-H. | Clinical Infectious Diseases | 4 | 4 | |
2005 | Prevalence and clinical implications of HFE gene mutations (C282Y and H63D) in patients with chronic hepatitis B and C in Taiwan | Mah Y.-H.; JIA-HORNG KAO ; CHUN-JEN LIU ; CHI-LING CHEN ; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN | Liver International | 24 | 17 | |
2002 | Prevalence and implication of a newly identified infectious agent (SEN virus) in Taiwan | JIA-HORNG KAO ; Chen W.; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN | Journal of Infectious Diseases | 56 | 47 | |
1999 | Prevalence and implication of TT virus infection: Minimal role in patients with non-A-E hepatitis in Taiwan | JIA-HORNG KAO ; Chen W.; Hsiang S.-C.; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN | Journal of Medical Virology | 48 | ||
2001 | Probable reinfection with hepatitis C virus in a chronic hepatitis C patient with a sustained response to combination therapy | JIA-HORNG KAO ; Lai M.-Y.; PEI-JER CHEN ; DING-SHINN CHEN | Journal of the Formosan Medical Association | 9 | 9 | |
2001 | Prolonged interferon treatment after combination interferon and ribavirin therapy in patients with chronic hepatitis C: A clinical trial of interferon relapsers and non-responders | JIA-HORNG KAO ; Lai M.-Y.; PEI-JER CHEN ; Cheng Y.-M.; DING-SHINN CHEN | Journal of the Formosan Medical Association | 0 | 2 | |
1995 | Prominent proliferative response of peripheral blood mononuclear cells to a recombinant non-structural (NS3) protein of hepatitis C virus in patients with chronic hepatitis C | PEI-MING YANG ; Hwang L.-H.; Lai M.-Y.; Huang W.-L.; Chu Y.-D.; Chi W.-K.; BOR-LUEN CHIANG ; JIA-HORNG KAO ; PEI-JER CHEN ; DING-SHINN CHEN | Clinical and Experimental Immunology | 8 | 7 | |
2003 | A prospective study characterizing full-length hepatitis B virus genomes during acute exacerbation | CHUN-JEN LIU ; PEI-JER CHEN ; Lai M.-Y.; JIA-HORNG KAO ; Chang C.-F.; Wu H.-L.; Shau W.-Y.; DING-SHINN CHEN | Gastroenterology | 58 | 54 | |
1993 | The protooncogene c‐jun is transactivated by the X protein of hepatitis B virus and highly expressed in liver cancer | ROBINSON W.-S.; Twu J.-S.; Lai M.-Y.; DING-SHINN CHEN | Journal of Gastroenterology and Hepatology | 2 | 0 | |
1995 | Quasispecies of hepatitis c virus and genetic drift of the hypervariable region in chronic type c hepatitis | JIA-HORNG KAO ; PEI-JER CHEN ; Lai M.-Y.; Wang T.-H.; Chen D.-S. | Journal of Infectious Diseases | 47 | 42 | |
2010 | The ratio of aminotransferase to platelets is a useful index for predicting hepatic fibrosis in hemodialysis patients with chronic hepatitis C | CHEN-HUA LIU ; Liang C.-C.; CHUN-JEN LIU ; SHIH-JER HSU ; JOU-WEI LIN ; Chen S.-I.; Hung P.-H.; Tsai H.-B.; Lai M.-Y.; PEI-JER CHEN ; Chen J.-H.; DING-SHINN CHEN ; JIA-HORNG KAO | Kidney International | 31 | 32 | |
2009 | Reactivation of hepatitis B virus in an inactive hepatitis B carrier with glucocorticoid pulse therapy | TAI-CHUNG TSENG ; CHUN-JEN LIU ; SONG-CHOU HSIEH ; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN ; JIA-HORNG KAO | Digestive and Liver Disease | 3 | 3 | |
2003 | Ribavirin and interferon is effective for hepatitis C virus clearance in hepatitis B and C dually infected patients | CHUN-JEN LIU ; PEI-JER CHEN ; Lai M.-Y.; JIA-HORNG KAO ; YUNG-MING JENG ; DING-SHINN CHEN | Hepatology | 118 | 94 |